Your search for

155 results were returned

  1. Twobirds news
    24 May 2019
    Bird & Bird advises FUJIFILM on the 100% acquisition of medwork
    www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-fujifilm-on-the-100-acquisition-of-medwork

    International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy

  2. Twobirds news
    05 April 2019
    Bird & Bird advises Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in Vakzine Projekt Management GmbH
    www.twobirds.com/en/news/press-releases/2019/germany/bird-and-bird-advises-serum-institute-of-india-pvt-ltd-on-the

    International law firm Bird & Bird advises Indian vaccine manufacturer Serum Institute of India Pvt. Ltd. on the acquisition of the majority share in German project management service provider Vakzine Projekt Management ...

  3. Twobirds news
    30 May 2019
    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
    www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  4. Legal news
    13 December 2017
    Patent Term Extensions
    www.twobirds.com/en/news/articles/2017/australia/patent-term-extensions

    In Australia the application of the Patent Term Extension provisions of the Patents Act 1990 have been construed narrowly so that PTEs are applicable to only certain types of pharmaceutical patents.

  5. Legal news
    19 April 2017
    Full Federal Court Confirms an Application to list on the PBS Prior to Patent Expiry is a non infringing Act
    www.twobirds.com/en/news/articles/2017/australia/full-federal-court-confirms-an-application-to-list-on-the-pbs-prior-to-patent-expiry

    Late last week, the Full Federal Court of Australia confirmed that the mere act of filing a Pharmaceutical Benefits Scheme (PBS) application for a generic pharmaceutical product is not, of itself, an act of infringement ...